跳至主要内容
临床试验/NCT07599605
NCT07599605已完成3 期

Efficacy of Rectal Indomethacin Plus Aggressive Hydration as Prophylaxis to Prevent Post-ERCP Pancreatitis at a Secondary-Care Teaching Hospital: A Randomized Controlled Trial.

Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年3月4日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
60
试验地点
1

研究概览

简要总结

Endoscopic retrograde cholangiopancreatography (ERCP) is a key procedure for managing biliopancreatic diseases, although it is associated with complications such as post-ERCP pancreatitis. This study assessed the efficacy of a prophylactic protocol combining rectal indomethacin with aggressive hydration to reduce the incidence of post-ERCP pancreatitis and serum amylase and lipase levels.

详细描述

A randomized controlled trial was conducted with 60 patients undergoing ERCP at a secondary-care teaching public hospital. Patients were divided into two groups: With and without prophylaxis. Differences in post-ERCP pancreatitis incidence and pancreatic enzyme levels before and after the procedure were analyzed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who required ERCP
  • Without contraindications to the use of indomethacin or aggressive hydration

排除标准

  • Patients with cardiac or renal alterations

研究者

发起方
Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Carlos R. Cervantes Sanchez

MD, MSc

Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo

研究点 (1)

Loading locations...

相似试验